Appasamy Associates Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Appasamy Associates Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $290.2K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Appasamy Associates Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $290.2K Trade | TransData Nexus

Appasamy Associates Private Limited

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $290.2K Total Trade · DGFT Verified

Appasamy Associates Private Limited is an Indian pharmaceutical exporter with a total trade value of $290.2K across 2 products in 2 therapeutic categories. Based on 24 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Device ($182.9K), Prednisone ($107.3K), .

Appasamy Associates Private Limited — Export Portfolio & Destination Treemap

Appasamy Associates Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Appasamy Associates Private Limited? — Company Overview & Market Position

Appasamy Associates Private Limited, incorporated on May 29, 2019, is a private Indian company specializing in the manufacture of medical, precision, and optical instruments. The company is registered under the Corporate Identification Number (CIN) U33201TN2019PTC129614 and is headquartered at No. 20, 1st Street SBI Officers Colony, Arumbakkam, Chennai, Tamil Nadu, 600106. As of the latest available data, Appasamy Associates has an authorized share capital of ₹32,00,00,000 and a paid-up capital of ₹31,37,75,170. The company is classified as a private, non-government entity and is not listed on any stock exchange. The most recent Annual General Meeting (AGM) was held on August 13, 2025, and the latest balance sheet was filed on March 31, 2025.

What Does Appasamy Associates Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Device$182.9K 2Prednisone$107.3K

Product Portfolio — Top 2 by Export Value

Appasamy Associates Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Device	Medical Devices & Diagnostics	$182.9K	21	0.7%	9
2	Prednisone	Respiratory	$107.3K	3	0.4%	9

Appasamy Associates Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $290.2K. The top category is Medical Devices & Diagnostics (63.0% of portfolio), followed by Respiratory (37.0%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Appasamy Associates Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Appasamy Associates operates manufacturing facilities in Chennai, Tamil Nadu, India. While specific details regarding plant capacities and specializations are not publicly disclosed, the company's focus on medical, precision, and optical instruments suggests that its facilities are equipped to produce a range of ophthalmic devices and related products. The company's subsidiaries, such as Ai Optics Private Limited and Appasamy Ocular Devices Private Limited, indicate a specialization in optical and ophthalmic products.

3Key Leadership

The leadership team of Appasamy Associates Private Limited includes:

Senthil Kumar Rathsarathy: Managing Director
Annaswamy Vaidheesh: Additional Director
Himanshu Vishnu Nema: Nominee Director

These individuals bring a wealth of experience in the medical and optical instrument manufacturing sectors, contributing to the company's strategic direction and operational success.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Appasamy Associates Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Appasamy Associates Private Limited's export activities, as per TransData Nexus proprietary trade data, include a total export value of $290,000 USD across 24 shipments, with products spanning two therapeutic categories. The top five products exported are a medical device valued at $183,000 USD and prednisone at $107,000 USD. The primary therapeutic categories are Medical Devices & Diagnostics (63.0%) and Respiratory (37.0%). However, specific details regarding regulatory filings, approvals, and market access status in the US, EU, UK, Australia, and Japan are not publicly available. The company's focus on medical devices and respiratory products suggests potential interest in these regulated markets, but further information is needed to assess their market presence and compliance status.

2Emerging Markets

Appasamy Associates Private Limited's export data indicates a concentration in medical devices and respiratory products, which are critical in emerging markets across Africa, Latin America, and Southeast Asia. While the company's WHO prequalification status is not publicly disclosed, obtaining such certification would enhance its ability to supply products to these regions, where access to quality medical devices is essential. The company's existing export activities suggest a strategic interest in expanding its presence in these emerging markets.

Geographic Strategy

Appasamy Associates Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Appasamy Associates Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company's export data indicates a focus on medical devices and respiratory products, which may require FDA approvals for the US market. However, without publicly accessible records, it is challenging to assess the company's compliance with FDA regulations and its standing in the US market.

2WHO & EU GMP

Appasamy Associates Private Limited's WHO prequalification status and EU Good Manufacturing Practice (GMP) certifications are not publicly disclosed. Obtaining WHO prequalification would enable the company to supply products to international markets, particularly in developing regions. EU GMP certification would facilitate access to the European market, ensuring compliance with stringent manufacturing standards. The company's export data suggests a focus on medical devices and respiratory products, which are subject to these certifications. However, without publicly available information, it is difficult to confirm the company's compliance with these international standards.

CDSCO & Indian Regulatory

Appasamy Associates Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Appasamy Associates Private Limited operates in the medical device and pharmaceutical sectors, focusing on products such as medical devices and respiratory medications. The company's export data indicates a concentration in these areas, with a total export value of $290,000 USD across 24 shipments. While specific competitors are not identified, the company's focus on medical devices and respiratory products suggests competition with other manufacturers in these therapeutic categories. A detailed market analysis is required to assess the company's position relative to competitors in overlapping categories and to understand market share dynamics.

2Key Differentiators

Appasamy Associates Private Limited's key differentiators include its specialization in medical devices and respiratory products, as indicated by its export data. The company's focus on these therapeutic areas suggests expertise and a targeted approach to meeting market needs. However, without detailed information on product offerings, manufacturing capabilities, and certifications, it is challenging to identify specific competitive advantages.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Appasamy Associates Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Appasamy Associates Private Limited's export data indicates a total export value of $290,000 USD across 24 shipments, with a concentration in Medical Devices & Diagnostics (63.0%) and Respiratory (37.0%) therapeutic categories. The company's focus on these product areas suggests a targeted approach to meeting market demands. However, without detailed information on supplier relationships, manufacturing processes, and quality control measures, it is challenging to fully assess the company's track record, export volume consistency, and reliability.

2Certifications to Verify

Importers should verify the following certifications when considering products from Appasamy Associates Private Limited:

FDA Approval: To ensure compliance with US regulations for medical devices and pharmaceutical products. Verification can be done through the FDA's official website or by contacting the company directly.

WHO-GMP Certification: To confirm adherence to international manufacturing standards. Verification can be done through the World Health Organization's official website or by contacting the company directly.

Frequently Asked Questions — Appasamy Associates Private Limited

How many pharmaceutical products does Appasamy Associates Private Limited export from India?

Appasamy Associates Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Device ($182.9K), Prednisone ($107.3K). Total export value is $290.2K.

What is Appasamy Associates Private Limited's total pharmaceutical export value?

Appasamy Associates Private Limited's total pharmaceutical export value is $290.2K, based on 24 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Appasamy Associates Private Limited cover?

Appasamy Associates Private Limited exports across 2 therapeutic categories. The largest are Medical Devices & Diagnostics (63.0%, 1 products), Respiratory (37.0%, 1 products).

Get Full Appasamy Associates Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.